BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 25402211)

  • 1. C/EBP transcription factors in human squamous cell carcinoma: selective changes in expression of isoforms correlate with the neoplastic state.
    Anand S; Ebner J; Warren CB; Raam MS; Piliang M; Billings SD; Maytin EV
    PLoS One; 2014; 9(11):e112073. PubMed ID: 25402211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of the CCAAT/enhancer-binding proteins C/EBPalpha, C/EBPbeta and C/EBPdelta in breast cancer: correlations with clinicopathologic parameters and cell-cycle regulatory proteins.
    Milde-Langosch K; Löning T; Bamberger AM
    Breast Cancer Res Treat; 2003 May; 79(2):175-85. PubMed ID: 12825852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and function of CCAAT/enhancer binding proteinbeta (C/EBPbeta) LAP and LIP isoforms in mouse mammary gland, tumors and cultured mammary epithelial cells.
    Dearth LR; Hutt J; Sattler A; Gigliotti A; DeWille J
    J Cell Biochem; 2001; 82(3):357-70. PubMed ID: 11500913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of mouse chondrocyte differentiation by CCAAT/enhancer-binding proteins.
    Okuma T; Hirata M; Yano F; Mori D; Kawaguchi H; Chung UI; Tanaka S; Saito T
    Biomed Res; 2015; 36(1):21-9. PubMed ID: 25749148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C/EBP transcription factors regulate SREBP1c gene expression during adipogenesis.
    Payne VA; Au WS; Lowe CE; Rahman SM; Friedman JE; O'Rahilly S; Rochford JJ
    Biochem J; 2009 Dec; 425(1):215-23. PubMed ID: 19811452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of aromatase P450 expression in endometriotic and endometrial stromal cells by CCAAT/enhancer binding proteins (C/EBPs): decreased C/EBPbeta in endometriosis is associated with overexpression of aromatase.
    Yang S; Fang Z; Suzuki T; Sasano H; Zhou J; Gurates B; Tamura M; Ferrer K; Bulun S
    J Clin Endocrinol Metab; 2002 May; 87(5):2336-45. PubMed ID: 11994385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of specific CCAAT/enhancer-binding protein isoforms in intestinal epithelial cells.
    Gheorghiu I; Deschênes C; Blais M; Boudreau F; Rivard N; Asselin C
    J Biol Chem; 2001 Nov; 276(47):44331-7. PubMed ID: 11559710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and DNA-binding activity of C/EBPalpha and C/EBPbeta in human liver and differentiated primary hepatocytes.
    Ferrini JB; Rodrigues E; Dulic V; Pichard-Garcia L; Fabr JM; Blanc P; Maurel P
    J Hepatol; 2001 Aug; 35(2):170-7. PubMed ID: 11580138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of CCAAT/enhancer binding proteins (C/EBP) is associated with squamous differentiation in epidermis and isolated primary keratinocytes and is altered in skin neoplasms.
    Oh HS; Smart RC
    J Invest Dermatol; 1998 Jun; 110(6):939-45. PubMed ID: 9620302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CCAAT/enhancer-binding protein beta (C/EBPbeta) and C/EBPdelta contribute to growth hormone-regulated transcription of c-fos.
    Liao J; Piwien-Pilipuk G; Ross SE; Hodge CL; Sealy L; MacDougald OA; Schwartz J
    J Biol Chem; 1999 Oct; 274(44):31597-604. PubMed ID: 10531366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CCAAT/enhancer-binding protein family members recruit the coactivator CREB-binding protein and trigger its phosphorylation.
    Kovács KA; Steinmann M; Magistretti PJ; Halfon O; Cardinaux JR
    J Biol Chem; 2003 Sep; 278(38):36959-65. PubMed ID: 12857754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CCAAT/enhancer binding proteins alpha and beta regulate the tumor necrosis factor receptor 1 gene promoter.
    Bristol JA; Morrison TE; Kenney SC
    Mol Immunol; 2009 Aug; 46(13):2706-13. PubMed ID: 19523687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diminished expression of C/EBPalpha in skin carcinomas is linked to oncogenic Ras and reexpression of C/EBPalpha in carcinoma cells inhibits proliferation.
    Shim M; Powers KL; Ewing SJ; Zhu S; Smart RC
    Cancer Res; 2005 Feb; 65(3):861-7. PubMed ID: 15705884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptional regulation of the human hepatic CYP3A4: identification of a new distal enhancer region responsive to CCAAT/enhancer-binding protein beta isoforms (liver activating protein and liver inhibitory protein).
    Martínez-Jiménez CP; Gómez-Lechón MJ; Castell JV; Jover R
    Mol Pharmacol; 2005 Jun; 67(6):2088-101. PubMed ID: 15778453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of mercuric chloride on the regulation of expression of the acute phase response components alpha(1)-acid glycoprotein and C/EBP transcription factors.
    Yiangou M; Scott SG; Rabek JP; An MR; Xiong W; Papaconstantinou J
    Biochim Biophys Acta; 2001 Mar; 1518(1-2):47-56. PubMed ID: 11267658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age-dependent response of CCAAT/enhancer binding proteins following traumatic brain injury in mice.
    Sandhir R; Berman NE
    Neurochem Int; 2010 Jan; 56(1):188-93. PubMed ID: 19833158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes of CCAAT enhancer-binding proteins (CEBPs) in the lung of streptozotocin-induced diabetic rats.
    Fong Y; Shen KH; Chen LJ; Cheng JT
    Horm Metab Res; 2011 Apr; 43(4):261-7. PubMed ID: 21249617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CCAAT/enhancer-binding protein beta inhibits proliferation in monocytic cells by affecting the retinoblastoma protein/E2F/cyclin E pathway but is not directly required for macrophage morphology.
    Gutsch R; Kandemir JD; Pietsch D; Cappello C; Meyer J; Simanowski K; Huber R; Brand K
    J Biol Chem; 2011 Jul; 286(26):22716-29. PubMed ID: 21558273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of CCAAT/enhancer-binding protein (C/EBP) activator proteins by heterodimerization with C/EBPgamma (Ig/EBP).
    Parkin SE; Baer M; Copeland TD; Schwartz RC; Johnson PF
    J Biol Chem; 2002 Jun; 277(26):23563-72. PubMed ID: 11980905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C/EBP-Family Redundancy Determines Patient Survival and Lymph Node Involvement in PDAC.
    Hartl L; Roelofs JJTH; Dijk F; Bijlsma MF; Duitman J; Spek CA
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.